Holen Sie sich die Stockscreener-App
1.63
4.68%
-0.08
Handel nachbörslich:
1.65
0.02
+1.23%
Schlusskurs vom Vortag:
$1.71
Offen:
$1.71
24-Stunden-Volumen:
154.19K
Relative Volume:
0.13
Marktkapitalisierung:
$100.06M
Einnahmen:
$5.03M
Nettoeinkommen (Verlust:
$-185.41M
KGV:
-0.5275
EPS:
-3.09
Netto-Cashflow:
$-139.79M
1W Leistung:
+0.62%
1M Leistung:
-4.12%
6M Leistung:
+20.74%
1J Leistung:
-87.29%
1-Tages-Spanne:
$1.60
$1.71
1-Wochen-Bereich:
$1.54
$1.73
52-Wochen-Spanne:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Firmenname
Pliant Therapeutics Inc
Sektor
Branche
Telefon
650-481-6770
Adresse
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Vergleichen Sie PLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.63 | 102.83M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2025-03-04 | Herabstufung | Needham | Buy → Hold |
| 2025-03-03 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-02-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-18 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-04-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-07 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2022-07-20 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | BTIG Research | Buy |
| 2021-04-05 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Cowen | Outperform |
| 2020-06-29 | Eingeleitet | Needham | Buy |
| 2020-06-29 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Does Pliant Therapeutics Inc. stock have upside surprise potentialJuly 2025 PostEarnings & Weekly Breakout Watchlists - khodrobank.com
How cyclical is Pliant Therapeutics Inc.’s revenue stream2025 Retail Activity & Capital Efficiency Focused Ideas - khodrobank.com
Pliant Therapeutics Inc. stock trendline breakdownWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Live market analysis of Pliant Therapeutics IncJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
What Fibonacci levels say about Pliant Therapeutics Inc. rebound2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Pliant Therapeutics Inc. stock split in the near future2025 Top Decliners & AI Powered Trade Plan Recommendations - Newser
Pliant Therapeutics Inc. stock volume spike explainedQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Analyzing drawdowns of Pliant Therapeutics Inc. with statistical toolsQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
How to use Fibonacci retracement on Pliant Therapeutics Inc.New Guidance & Free Technical Pattern Based Buy Signals - Newser
How to forecast Pliant Therapeutics Inc. trends using time seriesMarket Weekly Review & Momentum Based Trading Ideas - Newser
Live market analysis of Pliant Therapeutics Inc.Trade Entry Summary & Entry Point Strategy Guides - Newser
Sentiment analysis tools applied to Pliant Therapeutics Inc.2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Institutional scanner results for Pliant Therapeutics Inc.Dollar Strength & AI Based Buy and Sell Signals - Newser
What’s next for Pliant Therapeutics Inc. stock priceOil Prices & Risk Managed Investment Signals - Newser
Why Pliant Therapeutics Inc. is moving todayWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Is Pliant Therapeutics Inc. stock entering bullish territoryJuly 2025 Recap & Capital Efficiency Focused Ideas - Newser
Can swing trading help recover from Pliant Therapeutics Inc. lossesTrade Risk Assessment & Precise Trade Entry Recommendations - Newser
Can Pliant Therapeutics Inc. rally from current levelsQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Sector ETF performance correlation with Pliant Therapeutics Inc.July 2025 Selloffs & Risk Managed Investment Strategies - Newser
Strategies to average down on Pliant Therapeutics Inc.2025 Sector Review & Safe Entry Point Alerts - Newser
Is Pliant Therapeutics Inc. stock poised for growthMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
How to recover losses in Pliant Therapeutics Inc. stockQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
Will Pliant Therapeutics Inc. announce a stock splitProfit Target & Low Risk High Reward Trade Ideas - khodrobank.com
How to track smart money flows in Pliant Therapeutics Inc.Market Trend Review & Free Technical Confirmation Trade Alerts - Newser
Published on: 2025-09-02 05:09:14 - Newser
Is Pliant Therapeutics Inc. currently under institutional pressureBreakout Watch & Accurate Technical Buy Alerts - khodrobank.com
Pliant Therapeutics Inc. stock trend outlook and recovery pathTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
How liquid is Pliant Therapeutics Inc. stockPortfolio Performance Summary & Growth Focused Stock Pick Reports - khodrobank.com
Has Pliant Therapeutics Inc. formed a bullish divergenceVolume Spike & Precise Buy Zone Identification - Newser
What machine learning models say about Pliant Therapeutics Inc.2025 Retail Activity & Real-Time Price Movement Reports - Newser
Pliant Therapeutics Inc.’s volatility index tracking explainedBull Run & Consistent Return Strategy Ideas - Newser
Does Pliant Therapeutics Inc. have declining or rising EPSJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - khodrobank.com
Pliant Therapeutics Inc. Matches Institutional Buying FilterJuly 2025 Momentum & Community Verified Watchlist Alerts - beatles.ru
How to monitor Pliant Therapeutics Inc. with trend dashboards2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
How to build a custom watchlist for Pliant Therapeutics Inc.2025 Major Catalysts & High Conviction Trade Alerts - Newser
Ranking Pliant Therapeutics Inc. among high performing stocks via toolsMarket Trend Report & Long-Term Capital Growth Ideas - Newser
Identifying reversal signals in Pliant Therapeutics Inc.July 2025 Movers & Reliable Entry Point Alerts - Newser
Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pliant Therapeutics Inc-Aktie (PLRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont | Chief Financial Officer |
Jan 17 '25 |
Sale |
11.20 |
20,148 |
225,680 |
262,608 |
| Hull Hans | Chief Business Officer |
Jan 17 '25 |
Sale |
11.20 |
15,936 |
178,501 |
211,558 |
| Lefebvre Eric | Chief Medical Officer |
Jan 17 '25 |
Sale |
11.20 |
18,478 |
206,974 |
194,574 |
| Cheung Lily | Chief Human Resource Officer |
Jan 17 '25 |
Sale |
11.20 |
3,740 |
41,892 |
24,550 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 17 '25 |
Sale |
11.20 |
13,270 |
148,639 |
80,774 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 22 '25 |
Sale |
10.99 |
10,230 |
112,462 |
70,544 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):